Kendall Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Hold
4,540
0.04% 219
2025
Q4
$220K Sell
4,540
-145
-3% -$7.19K 0.05% 216
2025
Q3
$221K Sell
4,685
-50
-1% -$2.41K 0.05% 218
2025
Q2
$229K Buy
4,735
+80
+2% +$4.09K 0.06% 205
2025
Q1
$258K Hold
4,655
0.08% 194
2024
Q4
$225K Sell
4,655
-375
-7% -$19.1K 0.07% 204
2024
Q3
$290K Sell
5,030
-50
-1% -$2.7K 0.09% 185
2024
Q2
$246K Hold
5,080
0.08% 196
2024
Q1
$247K Sell
5,080
-500
-9% -$24.4K 0.08% 193
2023
Q4
$277K Sell
5,580
-10
-0.2% -$489 0.11% 176
2023
Q3
$300K Buy
5,590
+1,265
+29% +$67.4K 0.13% 156
2023
Q2
$233K Buy
+4,325
New +$233K 0.1% 179
2018
Q2
Sell
-7,200
Closed -$289K 114
2018
Q1
$289K Sell
7,200
-1,425
-17% -$59.3K 0.25% 87
2017
Q4
$371K Buy
+8,625
New +$398K 0.33% 79

Other funds holding SNY

Kendall Capital Management's SNY Position: Q1 2026 in Review

Kendall Capital Management held its Sanofi (SNY) position steady in Q1 2026 at 4,540 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #219.

Kendall Capital Management first reported a position in SNY in Q4 2017 and has held it in 14 quarters since. The position peaked at $371K in Q4 2017. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Kendall Capital Management held 4,540 shares of Sanofi worth $219K as of Q1 2026.
  • Kendall Capital Management left its Sanofi share count unchanged in Q1 2026.
  • Sanofi made up 0.04% of Kendall Capital Management's portfolio in Q1 2026, its #219 holding.
  • Kendall Capital Management first reported a position in Sanofi in Q4 2017 and has held it in 14 quarters since.
  • Kendall Capital Management's Sanofi position peaked at $371K in Q4 2017.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.